They changed the headline and edited the story (added more skeptics) to appease their DNC masters.
Statista: Covid deaths per million worldwide as of July 28, 2020
#1 Belgium (HOME OF THE EUROPEAN UNION) 859.91 per million
#72 India 24.7 per million
https://www.statista.com/statistics/1104709/coronavirus-deaths-worldwide-per-million-inhabitants/
15 July: Indian Express: Experts Explain: The case for using hydroxychloroquine (HCQ) to treat Covid-19
Hydroxychloroquine is obviously not a panacea for severe cases of Covid-19. Given early, it helps reduce mortality by about half, compared to those not given the drug.
by M S Seshadri, T. Jacob John
(Dr Seshadri is retired Professor of medical endocrinology, Christian Medical College, Vellore and currently Director, Thirumalai Mission Hospital Ranipet. Dr John is retired Professor of Clinical Virology, CMC, Vellore and Past President of Indian Academy of Pediatrics)
A study on more than 2,500 patients in six units under the Henry Ford Hospitals group in Detroit, Michigan, USA, peer-reviewed, accepted and ready for publication in the International Journal of Infectious Diseases, has found good evidence that HCQ reduces Covid-19 mortality significantly. It should be noted that conditions apply...
The story of HCQ and Covid-19 began in Wuhan, China, where patients who were on HCQ, attending rheumatology clinics, seemed to be relatively protected from serious Covid-19 than those attending other clinics. Looking for possible treatment options, Chinese physicians stumbled on HCQ . So they began using HCQ empirically for treating Covid-19...
French physicians, familiar with HCQ used against an endemic bacterial disease called Q fever, followed up with scientific studies for seeking objective evidence for HCQ use in Covid-19. There was laboratory evidence that HCQ acts against SARS coronavirus type 1 and, more recently, also against type 2 that causes Covid-19. The French reported that HCQ reduced both the viral load and duration of virus shedding in the upper respiratory tract of Covid-19 patients...
The Detroit study has swung the pendulum all the way back, favourable to HCQ use in Covid-19. If the scientific evidence from France was for reduction of viral load in the upper respiratory tract, was it not likely that it reflected a reduction of viral load in all other infected body tissues also?...
HCQ is obviously not a panacea for severe cases of Covid-19. Given early, it helps reduce mortality by about half, compared to those not given HCQ. In India the drug is widely available and not expensive. A number of Indian states have already incorporated a short course of HCQ in their Covid-19 treatment protocol, and states that have not done so will do well to implement this quickly.
Two other therapies for mortality reduction are a short course of dexamethasone and convalescent plasma. Indian physicians have a golden opportunity to use the three modalities in sequence – dexamethasone in those who do not improve with early use of HCQ and convalescent plasma for those who do not improve with dexamethasone. The outcome of this treatment sequence will inform the medical community how to save many lives.
https://indianexpress.com/article/explained/coronavirus-vaccine-hydroxychloroquine-hcq-covid-19-treatment-6504276/
And no zinc in the study. It’s almost like they set out to fail.